SOAT1 and primary cutaneous T-cell non-Hodgkin lymphoma: The Jak/Stat pathway was, likewise, proposed to induce malignant T cell expression of another inhibitory B7 family member, namely PD-L1 (B7-H1), which has been implicated in benign T cell suppression and tumor immune evasion in CTCL [97–100].